Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

NovoCure Tumor Treating Fields Shows Improved Outcomes In Tough Pancreatic Cancer - NovoCure (NASDAQ:NVCR)

Summary by Benzinga
NovoCure shares rise after PANOVA-4 data show higher disease control and survival signals in metastatic pancreatic cancer. Importance Rank:  1

3 Articles

BenzingaBenzinga
Center

NovoCure Tumor Treating Fields Shows Improved Outcomes In Tough Pancreatic Cancer - NovoCure (NASDAQ:NVCR)

NovoCure shares rise after PANOVA-4 data show higher disease control and survival signals in metastatic pancreatic cancer. Importance Rank:  1

·New York, United States
Read Full Article
The Daily NewsThe Daily News
Reposted by
HealthTech HotSpotHealthTech HotSpot
Center

Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer

BAAR, Switzerland--(BUSINESS WIRE)--Mar 26, 2026-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Daily News broke the news on Thursday, March 26, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Baar icon

Baar

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal